Cas No.: 1332850-08-4
PRODUCT INFORMATION
Description
Breast cancer-targeting peptide 18-4 (WxEAAYQrFL) is a KRT1 receptor-specific ligand with a reported Kd of ~1.1 μM. This proteolytically stable analogue of the P160 peptide enables precise targeting through KRT1-mediated internalization in research models. It has been shown to enhance cellular uptake and exhibits in vitro cytotoxic activity when covalently conjugated with agents like MccJ25.
Molecular Weight
1296.47
Purity
> 95%
Formula
C₆₃H₈₉N₁₅O₁₅
Product Type
Targeting Peptide
Sequence
Trp-D-Nle-Glu-Ala-Ala-Tyr-Gln-D-Arg-Phe-Leu
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- CGGRGD TFA Targeting Peptide (CAT#: OLY-1025-YS-57)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.